Non thiazolidinedione antihyperglycaemic agents. 1: α-Heteroatom substituted β-phenylpropanoic acids

Bioorganic and Medicinal Chemistry Letters

Volumn 6, Issue 17, 1996, Pages 2121-2126

  Buckle, D R ^a   Cantello, B C C ^a   Cawthorne, M A ^a   Coyle, P J ^a   Dean, D K ^a   Faller, A ^a   Haigh, D ^a   Hindley, R M ^a   Jefcott, L J ^a   Lister, C A ^a   Pinto, I L ^a   Rami, H K ^a   Smith, D G ^a   Smith, S A ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; BRL 48482; HYDROCINNAMIC ACID DERIVATIVE; SB 213068; STEROID RECEPTOR; TROGLITAZONE; UNCLASSIFIED DRUG;

ARTICLE; DRUG DESIGN; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; INSULIN SENSITIVITY; STRUCTURE ACTIVITY RELATION;

EID: 0030567857     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-894X(96)00383-6     Document Type: Article

References (36)

1. Reaven, G. M., Diabetes, 1988, 37, 1595-1607.
2. (a) Epstein, M. and Sowers, J. R., Hypertension, 1992, 19, 403-418.
3. (b) Landsberg, L., Hypertension, 1992, 19 (Suppl. I), 161-166.
4. Ruderman, N. B. and Schneider, S. H., Diabetes Care, 1992, 15 (Suppl. 4), 1787-1793.
5. Bailey, C. J., Proc. Nutrition Soc., 1991, 50, 619-630.
6. Ferner, R. E. and Neil, H. A. W., Br. Med. J., 1988, 296, 949-950.
7. (a) Larson, E. R.; Clark, D. A. and Stevenson, R. W., Ann. Reports Med. Chem., 1989, 25, 205-213.
8. (b) Colca, J. R. and Tanis, S. P., Ann. Reports Med. Chem., 1992, 27, 219-226.
9. (c) Dow, R. L. and Kreutter, D. K., Ann. Reports Med. Chem., 1995, 30, 159-168.
10. (a) Sohda, T.; Mizuno, K.; Imamiya, E.; Sugiyama, Y.; Fujita, T. and Kawamatsu, Y., Chem. Pharm. Bull., 1982, 30, 3580-3600.
11. (b) Fujita, T.; Sugiyama, Y.; Taketomi, S.; Sohda, T.; Kawamatsu, Y.; Iwatsuka, H. and Suzuoki, Z., Diabetes, 1983, 32, 804-810.
12. Momose, Y.; Meguro, K.; Ikeda, H.; Ot, S. and Sohda, T., Chem. Pharm. Bull., 1991, 39, 1440-1445.
13. Yoshioka, T.; Fujita, T.; Kanai, T.; Aizawa, Y.; Kurumada, T.; Hasegawa, K. and Horikoshi, H., J. Med. Chem., 1989, 32, 421-428.
14. (a) Cantello, B. C. C.; Cawthorne, M. A.; Haigh, D.; Hindley, R. M.; Smith, S. A. and Thurlby, P. L., Bioorg. Med. Chem. Lett., 1994, 4, 1181-1184.
15. (b) Cantello, B. C. C.; Cawthorne, M. A.; Cottam, G. P.; Duff, P. T.; Haigh, D.; Hindley, R. M.; Lister, C. A.; Smith, S. A. and Thurlby, P. L., J. Med. Chem., 1994, 37, 3977-3985.
16. See for example, (a) Sohda, T.; Mizuno, K.; Tawada, H.; Sugiyama, Y.; Fujita, T. and Kawamatsu, Y., Chem. Pharm. Bull., 1982, 30, 3563-3573.
17. (b) Dow, R. L; Bechle, B. M.; Chou, T. T.; Clark, D. A.; Hulin, B. and Stevenson, R. W., J. Med. Chem., 1991, 34, 1538-1544.
18. (c) Kees, K. L.; Smith, T. M.; McCaleb, M. L.; Prozialeck, D. H.; Cheeseman, R. S.; Christos, T. E.; Patt, W. C. and Steiner, K. E., J. Med. Chem., 1992, 55, 944-953.
19. (d) Ellingboe, J. W.; Alessi, T. R.; Dolak, T. M.; Nguyen, T. T.; Tomer, J. D.; Guzzo, F.; Bagli, J. F. and McCaleb, M. L., J. Med. Chem., 1992, 35, 1176-1183.
20. (e) Goldstein, S. W.; McDermott, R. E.; Gibbs, E. M. and Stevenson, R. W., J. Med. Chem., 1993, 36, 2238-2240.
21. (f) Ellingboe, J. W.; Lombardo, L. J.; Alessi, T. R.; Nguyen, T. T.; Guzzo, F.; Guinosso, C. J.; Bullington, J.; Browne, E. N. C.; Bagli, J. F.; Wrenn, J.; Steiner, K. and McCaleb, M. L, J. Med. Chem., 1993, 36, 2485-2493.
22. (g) Kees, K. L.; Caggiano, T. J.; Steiner, K. E.; Fitzgerald, J. J.; Kates, M. J.; Christos, T. E.; Kulishoff, J. M.; Moore, R. D. and McCaleb, M. L., J. Med. Chem., 1995, 38, 617-628.
23. During the course of our work we became aware of similar studies being conducted by the Pfizer group. Hulin, B., International Patent Appl., Publication No. WO91/19702, 1991.
24. (a) Kawamatsu, Y.; Asakawa, H.; Saraie, T.; Imamiya, E.; Nishikawa, K. and Hamuro, Y., Arzneim.-Forsch., 1980, 30, 585-589.
25. (b) Kawamatsu, Y.; Asakawa, H.; Saraie, T.; Mizuno, E.; Imamiya, E.; Nishikawa, K. and Hamuro, Y., Arzneim.-Forsch., 1980, 30, 751-758..
26. -1 diet) which reduces the area under the glucose tolerance curve by 25% relative to controls.
27. Haigh, D., International Patent Appl., Publication No. WO93/21166, 1993.
28. Faller, A., International Patent Appl., Publication No. W094/29285, 1994.
29. Hydrolysis of simple esters in vivo is known to be a facile process. Caldwell, J. and Mitchell, S. C. in Comprehensive Medicinal Chemistry, ed. Taylor, J. B., Pergamon, 1990, vol. 5, p. 151.
30. Haigh, D. and Sime, J. T., International Patent Appl., Publication No. WO94/01420, 1994.
31. (a) Lehmann, J. M.; Moore, L. B.; Smith-Oliver, T. A.; Wilkison, W. O.; Willson, T. M. and Kliewer, S. A., J. Biol. Chem., 1995, 270, 12953-12956.
32. (b) Forman, B. M.; Tontonoz, P.; Chen, J.; Brun, R. P.; Spiegelman, B. M. and Evans, R. M., Cell, 1995, 83, 803-812.
33. (c) Willson, T. M.; Cobb, J. E.; Cowan, D. J.; Wiethe, R. W.; Correa, I. D.; Prakash, S. R.; Beck, K. D.; Moore, L. B.; Kliewer, S. A. and Lehmann, J. M., J. Med. Chem., 1996, 39, 665-668.
34. -1 diet in ob/ob mice) was present at 145 pM. Competing compounds were dissolved in DMSO (concentration of DMSO did not exceed 0.1%). Binding was allowed to reach equilibrium by incubation for 18 hours at 4°C. Bound ligand was separated from free on mixed cellulose ester filters. Each assay was performed in triplicate.
35. Cox, G. G.; Haigh, D.; Hindley, R. M.; Miller, D. J. and Moody, C. J., Tetrahedron Lett., 1994, 35, 3139-3142.
36. Haigh, D., Tetrahedron, 1994, 50, 3177-3194.